Growing community of inventors

San Diego, CA, United States of America

Katherine Doores

Average Co-Inventor Count = 14.01

ph-index = 2

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 29

Katherine DooresJennifer L Mitcham (6 patents)Katherine DooresDennis R Burton (6 patents)Katherine DooresOle Olsen (6 patents)Katherine DooresMatthew Moyle (6 patents)Katherine DooresPo-Ying Chan-Hui (6 patents)Katherine DooresSanjay K Phogat (6 patents)Katherine DooresWayne C Koff (6 patents)Katherine DooresSteven Frey (6 patents)Katherine DooresStephen Kaminsky (6 patents)Katherine DooresPascal Raymond Georges Poignard (6 patents)Katherine DooresMelissa Danielle De Jean De St Marcel Simek-Lemos (6 patents)Katherine DooresMichael Huber (6 patents)Katherine DooresLaura Majorie Walker (4 patents)Katherine DooresLaura Marjorie Walker (2 patents)Katherine DooresKatherine Doores (6 patents)Jennifer L MitchamJennifer L Mitcham (60 patents)Dennis R BurtonDennis R Burton (53 patents)Ole OlsenOle Olsen (33 patents)Matthew MoyleMatthew Moyle (32 patents)Po-Ying Chan-HuiPo-Ying Chan-Hui (27 patents)Sanjay K PhogatSanjay K Phogat (25 patents)Wayne C KoffWayne C Koff (25 patents)Steven FreySteven Frey (21 patents)Stephen KaminskyStephen Kaminsky (19 patents)Pascal Raymond Georges PoignardPascal Raymond Georges Poignard (16 patents)Melissa Danielle De Jean De St Marcel Simek-LemosMelissa Danielle De Jean De St Marcel Simek-Lemos (14 patents)Michael HuberMichael Huber (6 patents)Laura Majorie WalkerLaura Majorie Walker (4 patents)Laura Marjorie WalkerLaura Marjorie Walker (10 patents)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. The Scripps Research Institute (6 from 1,189 patents)

2. International Aids Vaccine Initiative (6 from 69 patents)

3. Theraclone Sciences, Inc. (6 from 28 patents)


6 patents:

1. 12410243 - Methods of treating HIV-1 infection utilizing broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibodies

2. 11845789 - Methods of treating HIV-1 infection utilizing broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibodies

3. 11319362 - Methods of treating HIV-1 infection utilizing broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibodies

4. 10836811 - Broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibody

5. 10087239 - Broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibody

6. 9464131 - Broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibody

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
1/23/2026
Loading…